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Abstract 
Hyaluronan (HA) and its principal receptor CD44 are known to be involved in regulating tumor cell 
dissemination and metastasis. It is hypothesized that the CD44-HA interaction regulates proliferation 
and invasion of tumor cells in dependence on the molecular weight and the presentation form of HA. 
To address this hypothesis, we reconstituted 3D collagen (Coll I) matrices and functionalized them with 
HA of molecular weight of 30-50 kDa (low molecular weight; LMW-HA) and 500-750 kDa (high 
molecular weight; HMW-HA). A post-modification strategy was applied to covalently immobilize HA 
to reconstituted fibrillar Coll I matrices, resulting in a non-altered Coll I network microstructure and 
stable immobilization over days. Functionalized Coll I matrices were characterized regarding 
topological and mechanical characteristics as well as HA amount using confocal laser scanning 
microscopy, colloidal probe force spectroscopy and quantitative Alcian blue assay, respectively. To 
elucidate tumor cell behavior, BRO melanoma cell lines with and without CD44 receptor expression 
were used for in vitro cell experiments. We demonstrated that only soluble LMW-HA promoted cell 
proliferation in a CD44 dependent manner, while HMW-HA and immobilized LMW-HA did not. 
Furthermore, an enhanced cell invasion was found only for immobilized LMW-HA. Both findings 
correlated with a very strong and specific adhesive interaction of LMW-HA and CD44+ cells quantified 
in single cell adhesion measurements using soft colloidal force spectroscopy. Overall, our results 
emphasize the importance of presentation mode and molecular weight specificity in biomaterial studies 
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1. Introduction 
 Hyaluronan (HA) is ubiquitously present in the extracellular matrix (ECM) of all vertebrate 
tissues. Besides the widely known space-filling and lubricating properties of HA, it controls in a specific 
manner tissue homeostasis and biomechanical integrity, and is involved in many physiological and 
pathological processes [1,2]. Especially in solid tumors, the higher expression of HA is correlated with 
aggressive malignancy both in preclinical models and in patients [3,4]. 
HA is a linear polysaccharide of repeating non-sulfated disaccharide units consisting of glucuronic acid 
and N-acetylglucosamine. HA is highly charged at physiological pH due to the abundance of carboxyl 
and hydroxyl groups leading to a highly swollen and hydrated state [5,6]. HA synthesis occurs at the 
intracellular side of the cell membrane of fibroblasts and is regulated by 3 types of integral membrane 
proteins, namely HA synthases: HAS1, HAS2 and HAS3. Typically, HAS enzymes produce HA of 
different size by repeatedly adding glucuronic acid and N-acetylglucosamine to the growing 
polysaccharide chain [7]. HAS enzymes usually synthesize HA of a size between 200 to 2000 kDa at 
physiological conditions [8]. The degradation of HA is tightly controlled by hyaluronidases (HYAL) by 
hydrolyzing the glycosidic bond between the 2 subunits resulting in the production of fragments of 
different sizes [3]. Therefore, the regulation of HA synthesis and degradation is essential for ECM 
homeostasis and other biological processes. Importantly, HA molecular weight has been reported to 
strongly affect biological function of HA with frequently opposing effects on cellular behavior [1,9–
11]. High molecular weight HA (HMW-HA; MW > 500 kDa; formed under homeostatic conditions) 
inhibits cell proliferation, acts anti-angiogenic, anti-inflammatory and immunosuppressive [12,13]. In 
contrast, shorter fragments of HA (i.e. low molecular weight HA (LMW-HA); MW 20 – 200 kDa) 
originating from HMW-HA degradation by HYAL [1,14] and reactive oxygen species [15], enable cell 
migration, initiate angiogenesis and act pro-inflammatory and pro-angiogenic [6,9,16]. In tumor 
development, LMW-HA was found to be the predominant HA form in several malignant tumors [17–
19]. Although there exists some hypotheses for the contrasting impact of the different forms of HA on 
cell behavior (see below), a clear explanation is still lacking. This ongoing discussion is additionally 
interfered by contradicting findings for different settings of HA presentation [1,20]. Many studies 
(especially in vitro) use HA supplements in cell culture medium without any option and definition of its 
binding state to surrounding cell culture supports as is the case in vivo. This marked difference to the 
covalently bound state of the in vivo ECM strongly questions the significance of the impact of HA MW. 
Up to now the binding state of HA with different MW was hardly addressed in such studies. 
Many specific biological functions of HA rely on the interaction of HA with its principal 
receptors CD44, receptor for HA mediated motility (RHAMM) and intercellular adhesion molecule-1 
(ICAM-1). Among those receptors, CD44 is the best characterized and most prominent HA receptor and 
has raised strong interest concerning its impact on tumor progression and metastasis [21,22]. CD44 
categorizes a huge family of transmembrane glycoproteins, belonging to the class of cell adhesion 
molecules [23]. It is a ubiquitous, multi-structural and multifunctional cell surface molecule. CD44 is 
expressed in many cell types, including fibroblasts, leukocytes, epithelial cells, keratinocytes, stem cells 
as well as most tumor cells. Its ability to bind HA is tightly regulated [12,24,25]. CD44 is known to be 
involved in many cellular processes, e.g. cell adhesion, proliferation and migration [24,26,27]. In tumor 
tissue, high levels of CD44 expression have been observed in numerous tumor cell types and appear to 
be important in tumor metastasis and development [12,23,27]. The mechanism of CD44-HA interaction 
is suggested to rely on switches of CD44 between an inactive, non-binding state and an active HA-
binding state. It has been reported that the HA-binding domain of CD44 adopts 2 different 
conformations, resulting in high- and low-affinity states [25]. The non-binding O-state is marked by a 
folded C-terminal segment, which is partially disordered upon ligand binding and switching to their PD-
state [28]. All transcript variants of CD44 share the same HA-binding motif in the N-terminus, whereas 
the alternative exons are located in the extracellular stem part of the molecule. Therefore, HA-binding 
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seems to be similar for the known transcript variants. Different mechanisms of CD44-HA signaling are 
discussed in respect to HA MW in order to explain findings of MW dependence in cellular behavior. It 
has been reported, that LMW-HA directly triggers CD44 signal transduction via activation of merlin, 
PI3K and Erk signaling, resulting in enhanced growth, invasion and motility. Contrary, HMW-HA 
downregulates CD44 signaling mediators [26]. However, as mentioned above, binding state of HA to 
the ECM and in vitro mimicking were typically not well controlled. 
 The impact of the biophysical characteristics of the ECM, namely network topology, matrix 
stiffness as well as the 3D character has become a major issue in understanding tumor cell behavior. In 
order to mimic such properties in in vitro cell culture systems, several approaches using fibrillary 
networks from natural biopolymers (e.g. collagen type I (Coll I)), as well as hydrogels based on synthetic 
polymers or macroporous polymer scaffolds have been evolved as relevant models during the last 
decades [29–31]. Among those biomaterials collagen based matrices have the advantage to display many 
key characteristics of the in vivo ECM, including high abundance, fibrillar character, micrometer-sized 
porosity, expression of native ligands for cell receptors and other ECM molecules as well as low 
stiffness. Furthermore, Coll I based matrices are well known to be readily adjustable in various important 
ECM properties, e.g. topology [32–34], matrix modulus [35–38] and functionalization with other ECM 
components, including glycosaminoglycans (GAG) [39–42]. Hence, Coll I based scaffolds are 
suggested to be advantageous tools to study CD44-HA interaction in dependence on MW and binding 
status of HA and its impact of tumor cell behavior. 
 
2. Materials and methods 
2.1. Polymer coating of glass coverslips 
Covalent binding of Coll I on a glass surface improves the stability and practical handling of 3D Coll I 
matrices. For this purpose, poly(styrene-alt-maleic anhydride) (PSMA; MW = 30000 g/mol) (Sigma-
Aldrich, Steinheim, Germany) copolymer coated glass coverslips were prepared as previously reported 
[43]. Briefly, 13 mm coverslips (VWR International, Leuven, Belgium) were pre-cleaned and 
aminosilanized. Subsequently, coverslips were spin-coated with PSMA (0.14% v/v dissolved in 
tetrahydrofuran) at 4000 rpm for 20 s. The glass coverslips were tempered for 2 h at 120°C to ensure 
the availability of reactive anhydride groups prior to use. 
 
2.2. Reconstitution of 3D Coll I matrices 
The reconstitution of 3D Coll I matrices was performed on PSMA-coated 13 mm glass coverslips. Coll 
I matrices at the concentration of 1.5, 2.0 and 2.5 mg/ml were reconstituted by mixing rat tail Coll I 
solution (Corning, Berlin, Germany) with phosphate buffer with an ionic strength of 250 mM at pH 7.5. 
Coll I solution was prepared on ice to inhibit early fibrillation. Subsequently, 430 µl Coll I solution was 
transferred onto PSMA-coated coverslips and 400 µl were subsequently removed (30 µl of Coll I 
solution remained on the coverslip). Coll I fibrillation was carried out at 37 °C, 5% CO2 and 95% 
humidity for 90 min. To prevent the matrix from drying, matrices were kept in phosphate buffer saline 
(PBS; Biochrom, Berlin, Germany) prior to use. 
 
2.2. Cross-linking of 3D Coll I matrices 
Reconstituted Coll I matrices were cross-linked with N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC; Sigma-Aldrich) by incubation with 4 mg/mL EDC dissolved in 100 mM in 2-(N-
morpholino)ethanesulfonic acid (MES; Sigma-Aldrich) at pH 5 for 2 h at room temperature, as 
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previously reported [44]. Subsequently, matrices were rinsed 3 times with PBS and stored in a hydrated 
state prior to use. 
 
2.3. HA immobilization into 3D Coll I matrices 
HA was covalently immobilized using EDC cross-linker, as previously reported [42]. Briefly, HA with 
a molecular weight of 30-50 kDA (LMW-HA) and 500-750 kDA (HMW-HA) (Contipro Biotech. s.r.o., 
Dolni Dobrouc, Czech Republic) was dissolved in 100 mM MES buffer at pH 5 at a HA concentration 
of 0.1 mg/ml. Reconstituted 3D Coll I matrices were incubated with prepared HA solution at room 
temperature for 2 h. Subsequently, HA solution was removed and EDC cross-linking solution (as 
described in cross-linking session) was directly added without washing. Matrices were incubated with 
EDC cross-linking solution for 2 h at room temperature and followed by washing 3 times each 5 min 
with PBS. Prior to cell experiments, matrices were equilibrated in cell culture medium for 1 h. 
 
2.4. Quantitative analysis of topological and mechanical properties 
For the analysis of topological parameters i.e. pore size and fibril size, confocal image stacks of the Coll 
I matrices were acquired with a confocal laser scanning microscope 700 (cLSM 700; Carl Zeiss 
Microscopy, Jena, Germany), as previously reported [33,45]. Briefly, in order to visualize Coll I 
microstructure, Coll I matrices were incubated with 50 µM carboxytetramethylrhodamine-succinimidyl 
ester (TAMRA-SE; Invitrogen, Carlsbad, USA) solution (prepared in PBS) at room temperature for 
60 min. Thereafter, Coll I matrices were rinsed 3 times each 5 min with PBS. Coll I matrix 
microstructure were imaged with a 40× oil immersion objective (NA 1.3; Carl Zeiss Microscopy) in 
fluorescence mode. Obtained images were 16 bit color-depth with a resolution of 1024×1024 pixels and 
with a vertical stack size of 11 images (equivalent to 50 µm). The voxel width in xyz dimension was 
0.21×0.21×5 µm. Image stacks were analyzed using a home-built image analysis tool written in 
MATLAB (MathWork, Massachusetts, USA). Quantitative analysis of pore size was achieved using an 
erosion method, and fibril diameter was calculated using 2D autocorrelation [45].  
To determine the bulk matrix elasticity of Coll I matrices, colloidal force spectroscopy was used, 
as previously reported [33]. Briefly, a tip-less, rectangular cantilever was prepared by attaching a glass 
bead of 50 µm in diameter. At least 50 force-distance curves were measured at 3 positions of each Coll 
I matrix at room temperature with an indentation of 3–7 μm. The Young's modulus of the 3D Coll I 
matrices was determined from the force-distance curves by fitting the Hertz model. Topological and 
mechanical analyses were performed at least in triplicates. 
 
2.5. Analysis of HA localization 
The localization of immobilized HA in Coll I matrices was visualized using cLSM (LSM700, Carl Zeiss 
Microscopy). Modified and non-modified Coll I matrices were incubated with biotin coupled hyaluronic 
acid binding protein (HABP; dilution 1:1000 in PBS) (AMS Biotechnology, Frankfurt/M., Germany) 
for 60 min at room temperature and gentle shaking. After removal of biotin-HABP solution, Coll I 
matrices were washed 3 times each 5 min, and incubated with streptavidin-conjugated with 
DyLight™488 (dilution 1:1000) (BioLegend, Fell, Germany) for 60 min at room temperature and gentle 
shaking. Immobilized HA and Coll I microstructure were visualized using cLSM. Images were gathered 
with a 40× oil immersion objective (NA 1.3; Carl Zeiss Microscopy) in fluorescence mode. Obtained 
images were 16 bit color-depth with a resolution of 1024×1024 pixels and with a vertical stack size of 
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11 images (equivalent to 50 µm). The voxel width in xyz dimension was 0.21×0.21×5 µm. Localization 
analysis was performed in triplicates. 
 
2.6. Quantification of immobilized HA in 3D Coll I matrices 
The quantification of the content of immobilized HA in Coll I matrices was performed by using Alcian 
blue 8GX assay. Coll I matrices were digested with papain solution (0.02 mg/ml papain from papaya 
latex (Sigma-Aldrich), 10 mM EDTA (Sigma-Aldrich), 5 mM L-cysteine (Sigma-Aldrich) in 5× PBS 
for 2 h at 60°C. Subsequently, digested Coll I solution was incubated with Alcian blue 8GX (Sigma-
Aldrich) for 30 min at room temperature and gentle shaking. Alcian blue 8GX and HA react to form an 
insoluble HA-Alcian blue complex. The HA-Alcian blue complex was separated by centrifugation at 
15000 g for 15 min and 4 °C, followed by washing the sedimented complex 2 times with deionized 
water. Afterwards, HA-Alcian blue complex formation was reversed by adding 8 M guanidine 
hydrochloride (dissolved in deionized water) (Sigma-Aldrich). HA dependent dissolved Alcian blue was 
quantified by absorption measurements at 620 nm using UV/Vis-spectrophotometer (BioSpectrometer® 
basic; Eppendorf, Wesseling-Berzdorf, Germany). The absorption value was related to HA amount 
using a standard curve. HA amounts were analyzed after incubation of HA immobilized Coll I matrices 
for 1 and 5 days in PBS. All measurements were done at least in triplicates. 
To verify HA quantification by Alcian blue 8GX assay, fluorimetry of Atto565-labeled HA was 
performed after a protocol published recently [46]. Briefly, HA (MW 57 kDa) derived from ozonolysis 
of high molecular weight HA (from Streptococcus, MW 1 MDa, Aqua Biochem, Dessau, Germany) was 
conjugated with Atto565-NH2 (ATTO-TEC, Siegen, Germany) at carboxylic groups along the HA 
chain. HA immobilization was performed for Coll I matrices of different concentration as described 
above. Subsequently, matrices were digested using papain (see above) and solutions were analyzed for 
fluorescence intensity at λex = 535 nm and λem = 590 nm in 96-microplate reader (Infinite 200 PRO, 
Tecan, Männedorf, Switzerland). The fluorescence intensity was related to HA amount using a standard 
curve. HA amounts were analyzed after 1 day of incubation in PBS. All measurements were done at 
least in triplicates. 
 
2.7. Cell culture and quantification of cell number 
BRO cell line [47] expressing high levels of CD44 (transcript variant 4, NM_001001391, [48]) was used 
for the experiments. The cells were kept in RPMI-1640 supplemented with 10% fetal calf serum and 
1% ZellShield (Biochrom, Berlin, Germany) at 37 °C, 5% CO2 and 95% humidity. 
CD44 knockdown cell (BRO P10 or BRO CD44- cells) was achieved by CRISPR-CAS9 (D10A) 
mediated genome editing. Briefly, BRO cells were transfected with bi-cistronic plasmids expressing 
simultaneously sgRNA docking to exon 2 common to all CD44 transcript variants and CAS9 (DNA2.0, 
San Diego, CA, USA; for plasmid map see Figure S1). Clones with a complete loss of CD44 protein 
expression were obtained after limited dilution assay and by comprehensive analysis including flow 
cytometry (CD44-PE (clone DB105, MiltenyiBiotech, Bergisch-Gladbach, Germany) and Western blot 
analysis with anti-CD44-antibodies (clone SFF304 (ebioscience, Frankfurt, Germany), see Figure S2. 
1×104 cells were cultivated on non-modified and modified Coll I matrices in RPMI-1640 medium 
supplemented with 10% fetal calf serum and 1% ZellShield (anti-biotic) at 37 °C, 5% CO2 and 95% 
humidity for 4 days (all from Biochrom). 
To determine cell proliferation using commercial WST-1 assay (Cayman, Michigan, USA), matrices 
were washed 3 times with Hank´s buffered salt solution with calcium and magnesium (HBSS) 
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(Biochrom) and 300 µL of the WST-1 reaction mixture (1:10 dilution in RPMI-1640 cell culture medium 
without phenol red, Biochrom, Germany) were incubated for 60 min at standard cell culture condition. 
Subsequently, supernatant was collected and the absorption measurement at 450 nm was performed 
using 96-microplate reader. The relative amount of vital cells was normalized to non-modified Coll I 
matrices. Experiments were performed at least 6 times. 
 
2.8. Flow cytometry analysis of CD44 expression 
Flow cytometry analysis of CD44 expression was done prior to each cell experiment. Cells were 
detached from cell culture flasks using 10 mM ethylenediaminetetraacetic acid (EDTA) (Sigma-
Aldrich). Cells were centrifuged at 1500 rpm for 5 min and resuspended in PBS. Cells were fixed with 
4% paraformaldehyde (PFA; Roth, Germany) for 10 min and were centrifuged at 1500 rpm for 5 min. 
The cell pellet was resuspended in PBS and stained with anti-human/mouse CD44 IM7 APC antibody 
(dilution 1:100 in PBS) (Biolegend) for 15 min (gentle shaking). Thereafter, stained cells were washed 
in PBS and centrifuged at 1500 rpm for 5 min. 1×104 cells were analyzed using a flow cytometer FC 
500 (Beckman Coulter, Krefeld, Germany). 
 
2.9. Quantitative analysis of cell invasion 
To investigate the invasion behavior and morphology of cells after 4 days of cell culture, cells were 
fixed with 4% paraformaldehyde for 15 minutes. Subsequently, cells were stained with DAPI (dilution 
1:10.000 in PBS) and Alexa Fluor® 488 Phalloidin (dilution 1:100 in PBS) (both Invitrogen) for 60 min 
at room temperature. Quantitative analysis of cell invasion, e.g. invasion depth and percent of invasive 
cells, was analyzed using a home-built MATLAB script, as previously reported [33]. At least 3 positions 
of each sample were gathered using epi-fluorescence microscopy equipped with z-scan stage 
(AxioObserver.Z1; Carl Zeiss Microscopy). Image stacks were recorded with a 10×, NA 0.45 objective 
(Carl Zeiss Microscopy) in fluorescence mode (DAPI fluorescent signal) at 5 µm z distance (overall z-
depth was 400 µm). The 8-bit images were 1388 × 1040 pixels in resolution (xy dimension). 
Experiments were performed at least in triplicate. 
 
2.10. Quantification of CD44-HA adhesive interaction using soft colloidal probes  
The interaction between CD44 and HA, both LMW-HA and HMW-HA, was studied using soft colloidal 
probes (SCP) techniques, as previous reported [49]. Briefly, soft colloidal probes were synthesized by 
UV induced photo-polymerization of 6.3 µM PEG-diacrylamide (MW = 8000 Da; Sigma-Aldrich) 
followed by grafting with crotonic acid (Sigma-Aldrich) [50,51]. Thereafter, SCP was functionalized 
with HA using a two-step reaction. Firstly, 20 mM EDC (Sigma-Aldrich) was prepared in 0.1 M MES 
buffer (pH 5) (Sigma-Aldrich) supplemented with 1 mg/ml poly-L-lysine (PLL; 30-70 kDa; Sigma-
Aldrich). SCPs were incubated with the prepared EDC solution for 30 min at room temperature and 
gentle shaking. Subsequently, SCPs were washed 3 times with 0.1 M MES buffer (pH 5) and centrifuged 
at 5000 rpm for 5 min at room temperature. The second solution composed of 20 mM EDC and 1 mg/ml 
HA in 0.1 M MES buffer (pH 5) was prepared. The SCPs were incubated for 3 h at room temperature 
and gentle shaking, resulting in a covalent immobilization of HA to the SCPs. The functionalized SCPs 
with HA (HA-SCP) were washed 2 times with PBS and stored in PBS with 0.1 wt% sodium azide 
(Sigma-Aldrich) prior to use.  
 To perform the experiment, HA-SCP was glued to a non-coated cantilever (CSC12 nominal 
spring constant 0.03 N/m; NanoAndMore GmbH, Wetzlar, Germany) using an epoxy glue (Epoxy Resin 
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Adhesives (2-Component); UHU GmbH, Bühl, Germany). The experimental setup is depicted in 
Figure 6A. For the measurement, the cantilever was positioned above a cell and several force curves 
were recorded with a maximum contact force of 3 nN and contact times between 0 and 30 s. At least 40 
cells of both CD44- and CD44+ BRO melanoma cells were analyzed. 
Cell stiffness was derived from colloidal force spectroscopy measurements using force-deformation 
curves of both CD44+ and CD44- cells with cantilevers modified with colloidal glass beads (30-50 µm 
in diameter; PolySciences Inc, Warrington ,USA). Maximum indentation force was set to 5 nN and the 
indentation depth was approximately 1-2 µm. The elastic moduli of at least 40 cells were analyzed via 
the Hertz contact model (Figure S6). 
 
2.11. Statistical analysis 
 Data are presented as means ± standard deviation. Significant analysis was assessed by one-way 
ANOVA test and accepted as statistically significant at p < 0.05 using OriginPro 8 (OriginLab, USA). 
If not otherwise stated, experiments were performed at least triplicates.  
 
3. Results and discussion 
In order to investigate the influence of HA molecular weight and presentation mode in solid tumor 
microenvironment, HA with a molecular weight of 30-50 kDa (LMW-HA) and of 500-750 kDa (HMW-
HA) was covalently immobilized to reconstituted Coll I matrices. Immobilized amount of HA and its 
impact on topological and mechanical parameters of the matrices were evaluated. To elucidate the 
interaction between CD44 and HA, BRO melanoma cell lines with and without CD44 expression were 
studied regarding proliferation, invasion and adhesion.  
 
3.1 Functionalization and characterization of HA immobilized Coll I matrices  
Coll I matrices were reconstituted at Coll I concentration of 1.5, 2.0 and 2.5 mg/ml, and subsequently 
modified with LMW-HA (30-50 kDa) or HMW-HA (500-750 kDa). A previous report demonstrated 
that functionalization of Coll I with GAG using post-modification and crosslinking by EDC provides a 
stable GAG immobilization in comparison to approaches using mixtures of GAG and Coll I during 
fibrillation [42]. Furthermore, this approach avoids variation in fibril micro- and nanostructure due to 
the GAG presence [52]. In Figure 1 the microstructure of non-modified, crosslinked Coll I and HA-
modified networks is depicted. As expected, the images show that an increase of Coll I concentration 
led to a higher fibril density. Crosslinked Coll I matrices with EDC and modification with HA of both 
molecular weights appear with a similar microstructure at corresponding concentration. Quantitative 
analysis of topological parameters revealed the pore size to decrease with increasing Coll I 
concentration, with 6.6 ± 0.7, 4.7 ± 0.6 and 3.1 ± 0.6 µm for 1.5, 2.0 and 2.5 mg/ml Coll I concentration, 
respectively (Figure 2A). EDC crosslinking and HA modification did not affect the pore size 
dependence. These observations are in agreement with previous reports [33,45]. The fibril diameter 
parameter of the autocorrelation analysis was approximately 700 nm for all matrices. The results suggest 
that post-modification with EDC crosslinker and covalent immobilization of HA did not alter Coll I 
matrix microstructure, confirming findings previously reported for various GAG [42].  
For the investigation of the HA localization in Coll I matrices, reconstituted matrices were 
stained with HABP-biotin/streptavidin DyLight488 and TAMRA-SE to visualize immobilized HA and 
Coll I fibrils, respectively. Representative images of HA immobilized Coll I matrices are shown in 
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Figure 1, suggesting uniform distribution of HA in 3D Coll I matrices. The image indicate that HA is 
localized on Coll I fibrils in agreement with our previous work [42]. 
 
Figure 1. Representative images of microstructure of non-modified and EDC and HA modified Coll I 
matrices. Coll I matrices were reconstituted at concentration of 1.5, 2.0 and 2.5 mg/ml at pH 7.5, and modified 
with EDC crosslinker and HA of different molecular weight, namely LMW-HA (30-50 kDA) and HMW-HA 
(500-750 kDa). To image matrix microstructure, Coll I was stained with TAMRA-SE. Both LMW-HA and 
HMW-HA were stained with hyaluronic acid binding protein (HABP) conjugated with biotin and subsequent 
staining with a Streptavidin-DyLight488™. Experiments were performed at least in three independent 
experiments. 
 
Beside topological parameters and HA localization, bulk matrix elasticity was analyzed using 
colloidal probe force spectroscopy. As shown in Figure 2B, Young`s modulus is increased by increasing 
Coll I concentration, namely 50 ± 16, 80 ± 30 and 150 ± 50 Pa for 1.5, 2.0 and 2.5 mg/ml Coll I 
concentration, respectively. As reported previously [32,33,45,53], the Young's modulus of Coll I 
matrices is proportional to an increasing Coll I concentration as a result of the decreasing fibril density 
and pore size. The bulk matrix stiffness of Coll I matrices can be increased using crosslinkers such as 
EDC [42,54] and glutaraldehyde [53]. In this study, EDC crosslinker was used because its properties as 
a zero-length cross-linker does not result in any alteration of Coll I microstructure [42]. By crosslinking 
with 20 mM EDC, stiffness of reconstituted Coll I matrices increased to 75 ± 30, 160 ± 80 and 220 ± 
100 Pa for 1.5, 2.0 and 2.5 mg/ml Coll I concentration, respectively. After immobilizing HA via EDC, 
an additional increase of matrix stiffness was observed (Figure 2B). This effect becomes less significant 
for high Coll I concentrations (2.0 and 2.5 mg/ml). Furthermore, no difference in matrix stiffness was 
observed depending on incorporation of LMW-HA or HMW-HA (Figure 2B). 
In summary, microstructure of Coll I matrices can be adjusted by Coll I concentration, but is 
unaltered by crosslinking and HA modification. However, bulk matrix stiffness increases not only with 
increasing fibril density (and corresponding smaller pore size), but is increased by crosslinking. A 
further small increase in matrix stiffness is observed by HA modification. The latter effect was also 
reported in other studies [42,55] and was attributed to the high water binding capacity of HA [56]. Either 
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the strong swelling of bound HA molecules increases the stiffness of Coll I fibrils or local osmotic 
effects of water binding in HA molecules impact intrafibrillar Coll I structure and mechanics as recently 
shown for rat tendons at varied humidity [57]. Although a minor effect is observed in our system, both 
mechanisms could contribute to a slight increase of Young`s modulus of Coll I with immobilized HA. 
 
 
Figure 2. Quantitative analysis of pore size and bulk matrix elasticity of non-modified and EDC and HA 
modified Coll I matrices. (A) pore size and (B) matrix elasticity analysis of Coll I matrices reconstituted at Coll 
I concentration of 1.5, 2.0 and 2.5 mg/ml at pH 7.5. Matrix post-modification was performed with EDC 
crosslinker and HA of different molecular weight, namely LMW-HA (30-50 kDa) and HMW-HA (50-750 kDa). 
Image-based pore size analysis was performed in three independent experiments with n=3 positions for each Coll 
I matrix. For matrix elasticity analysis using soft colloidal probe technique, about 50 force-distance curves were 
measured at 3 positions of each Coll I matrix within 3 independent experiments. Experiments were performed at 
least in three independent replicates. Data are shown as box plots: +...mean, box...median with 10th and 90th 
percentiles, error bars...minimum and maximum values. 
 
 
3.2 Stability and amount of HA in 3D Coll I matrices 
Prior to cell experiments it is of major importance to ensure a constant availability of HA. 
Quantitative analysis of immobilized HA amount was performed using Alcian blue assay. Alcian blue 
is a cationic dye binding to acidic polysaccharides through a complex formation [58,59]. Furthermore, 
we used our established fluorimetric protocol for fluorescent conjugated HA to verify the quantitative 
analysis of the Acian blue assay (Figure S3).  
By comparing amount of immobilized HA at day 1 and day 5 after matrix functionalization, 
ranging between 2 and 6 µg HA per Coll I matrix, HA could be verified to be stably immobilized on 
Coll I matrices as expected from our previous studies [42] (Figure 3A). Only a low, non-significant 
decrease of HA amount was observed. Furthermore, HA amount was found to depend on concentration 
of fibrillized Coll I and on molecular weight of HA. An increasing Coll I concentration led to an increase 
of immobilized HA for both LMW-HA and HMW-HA. Normalizing the absolute HA amount to the 
amount of fibrillized Coll I indicated 2 effects: (I) HA amount is directly related to amount of Coll I 
leading to a constant HA/Coll I ratio and (II) that this ratio is MW dependent with approx. 0.05 µg HA 
per µg Coll I for LMW-HA and 0.1 µg HA per µg Coll I for HMW-HA (Figure 3B). Both findings point 
to a dense immobilization of HA on the surface of Coll I fibrils in the matrices, as discussed in our 
previous study [42]. With increasing Coll I concentration a high number of fibrils (corresponding fibril 
surface) is available for HA immobilization, which compares well to the decreasing pore size 
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(Figure  2A). Furthermore, the different HA/Coll I ratios compare very well with the MW of the used 
HA. For our immobilization protocol in aqueous state and the dense packing of HA molecules on Coll 
I fibrils (see above), the amount of immobilized HA should be proportional to the hydrodynamic radius 
of HA molecules. The hydrodynamic radius of a compact polyelectrolyte at high ionic strength of 
solution should approximately scale with MW by an exponent of 1/3 [60]. The ratio of hydrodynamic 
radii of LMW-HA (≈40 kDa) and HMW-HA (≈625 kDa) estimated with the above assumption 
calculates to 0.4. This ratio roughly compares to the ratio of normalized HA amounts per Coll I for 
LMW-HA and HMW-HA being 0.5 supporting a dense packing of HA on Coll I fibrils. 
In summary, the analysis showed that HA is stable immobilized and densely packed on fibrillar 
Coll I matrices. 
 
 
Figure 3. Quantification of immobilized HA in 3D Coll I matrices. For quantitative analysis of immobilized 
HA amount in 3D Coll I matrices, matrices were digested with papain solution and the concentration of HA was 
analyzed using quantitative Alcian blue assay by absorption measurement at 621 nm. Concentration of 
immobilized HA was analyzed at day 1 and day 5 after network modification. (A) The immobilized amount of 
HA per Coll I matrix and (B) HA amount per Coll I amount (w/w) (µg/µg Coll I) are shown for Coll I 
concentrations of 1.5, 2.0 and 2.5 mg/ml. Data are shown as mean. Error bars represent standard deviation of 
mean. Analysis was performed in 4 independent experiments. 
 
 
3.3 Cell experiments 
Interactions between cells and extracellular HA are predominantly triggered by CD44, a multifunctional 
cell surface receptor implicated in a huge variety of intracellular signaling pathways. In order to address 
the interaction between tumor cells and their HA-rich microenvironment, BRO melanoma cell lines with 
(CD44+) and without CD44 (CD44-) receptor were applied in the cell studies. From our set of Coll I 
matrices we chose matrices with 2.5 mg/ml Coll I, because no considerable differences in matrix 
stiffness were observed between EDC crosslinked and HA modified (via EDC chemistry) matrices. This 
allowed us to focus on the impact of the HA presentation scheme for CD44 interaction. 
Prior to each cell experiments, BRO melanoma cells were analyzed regarding their expression of CD44 
using flow cytometry (Figure S2 A). 
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Unaffected cell morphology by HA MW and availability form 
To assess the morphological appearance of CD44+ and CD44- BRO melanoma cells on modified and 
non-modified Coll I matrices, cells were stained with DAPI (nucleus) and Phalloidin conjugated with 
Alexa Fluor® 488 (actin cytoskeleton), and analyzed using cLSM after 4 days of culture (Figure 4A). 
No remarkable difference in morphological appearance could be observed between CD44+ and CD44- 
BRO melanoma cells, both exhibit an epithelial, triangular or elongated ovoidal phenotype with a 
prominent nucleus and clearly visible nucleoli in all matrices. The results suggest that HA MW as well 
as HA availability form (soluble or immobilized) did not markedly modulate changes of cell morphology 
of both cell types. 
 
Figure 4. Morphology and proliferation analysis of BRO melanoma cells cultivated on 3D Coll I matrices 
with and without post-modification with EDC cross-linker and HA. BRO melanoma cells with and without 
CD44 expression were cultivated for 4 days on 3D Coll I matrices reconstituted at Coll I concentration of 2.5 
mg/ml at pH 7.5. Coll I matrices were either crosslinked with EDC (Coll-EDC) or post-modified with LMW-HA 
or HMW-HA (cHA: covalently immobilized HA) or optionally supplemented with soluble HA (sHA) at a 
concentration of 5 µg/ml. (A) Representative images of BRO melanoma cells on modified and non-modified 
matrices in the presence of HA in soluble and immobilized forms. Cells were stained with DAPI and Alexa 
Fluor® Phalloidin 488 to visualize cell nucleus and actin cytoskeleton. (B) Cell proliferation of BRO melanoma 
cells with CD44 expression was measured using WST-1. (C) Data from Figure 4B was rearranged to 
demonstrate the impact of soluble LMW-HA in modified and non-modified matrices. Data were normalized to 
non-modified Coll I matrices (Coll). Data are shown as mean. Error bars represent standard deviation of mean. * 
represents statistical significance with p ≤ 0.05.  Experiments were performed at least in 4 independent 
experiments. 
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Soluble LMW-HA enhanced proliferative capacity 
 In order to evaluate the impact of HA size and presentation form on proliferation via CD44 
interaction, cell proliferation of both BRO melanoma cell lines was analyzed after a cultivation period 
of 4 days using WST-1 assay. In Figure 4B, relative cell number normalized to non-modified Coll I 
matrices is depicted for CD44+ BRO melanoma cells. The proliferation of CD44- BRO melanoma cells 
was not influenced by EDC crosslinking and the presence of HA, independent of MW and presentation 
form (Figure S4).   
In contrast, the proliferation of CD44+ cells was regulated by the presence of LMW-HA, but not HMW-
HA (Figure 4B). The presence of LMW-HA led to distinct effects in dependence on its presentation 
form. In the presence of soluble LMW-HA (Figure 4C), cell number after 4 days was markedly increased 
by approximately 75% compared to non-modified Coll I. It is important to note, that the presence of 
soluble LMW-HA in combination with EDC crosslinking or LMW-HA immobilization (which also 
includes EDC crosslinking) increased the relative cell number by approximately 61% compared to 
crosslinked matrices without soluble LWM-HA. Immobilized LMW-HA was not found to be active in 
this context. On top of the impact to soluble LMW-HA we found cell proliferation to be slightly 
decreased by 25% due to crosslinking (either pure EDC or in the context of HA immobilization) in 
comparison to non-modified Coll I. 
The results indicate that the proliferation of BRO melanoma cells is regulated via CD44 in dependence 
on presence of soluble LMW-HA as well as EDC crosslinking. In the presence of LMW-HA in a 
covalently attached form as well as the presence of HMW-HA in any form did not affect the CD44 
dependent proliferation of BRO melanoma cells. It is followed that the CD44 dependent proliferative 
activity of LMW-HA depends on its presence in a soluble form, because it might be the prerequisite for 
internalization by CD44 and HYAL2 and subsequent intracellular signaling [28,61–63]. HMW-HA 
seems to be too large for this process, while covalent immobilization inhibits CD44 dependent 
internalization as well. An alternative interpretation could be based on differences in the mobility of the 
HA ligands. CD44 reorganization in the cell membrane after HA binding is known to affect its 
intracellular signaling [64]. Such a process would be also dependent on the presentation form of HA, 
with soluble LMW-HA being mobile, but covalently bound LMW-HA and HMW-HA being not or 
weakly mobile. Furthermore, our findings suggest an additive effect of matrix stiffness on the CD44 
dependent proliferation of BRO melanoma cells as proliferation is decreased on stiffer (crosslinked) 
matrix. This reduction of proliferation of CD44+ cells in EDC crosslinked matrices (compared to non-
modified matrices) might be caused by the interplay of CD44 with the mechanosensing via integrin 
receptors [65]. However, the activation of proliferation via soluble LMW-HA acts on top of this process. 
 
Immobilized LMW-HA triggered invasiveness 
We further investigated the role of CD44 in regulation of cell invasion regarding the number of invasive 
cells and their invasion depth. The quantification of invasive behavior was analyzed by DAPI staining 
using epi-fluorescence microscopy and a home-built MATLAB script counting detected cell numbers 
in image stacks with vertical size of 400 µm (Figure 5A and 5B). In all experiments, 50% of both CD44+ 
and CD44- cells migrated deeper than 20 µm into the Coll I matrix independent of the Coll I matrix 
modification (Figure S5). Furthermore, the maximum invasion distance of CD44- cells invaded was 
independent of HA MW and presentation form with approx. 30 µm (Figure 5C). A change of maximum 
invasive distance could be solely observed for CD44+ cells (Figure 5D). CD44+ cells cultivated on non-
modified Coll I matrices and EDC crosslinked matrices exhibited an invasion distance of approx. 50 
µm. In the presence of both, soluble and immobilized HMW-HA, maximum invasion distance was 
slightly decreased compared to cells cultivated on non-modified and EDC crosslinked matrices. 
However, immobilization of LMW-HA led to a remarkable increase of maximum invasion distance 
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being approx. 110 µm. In contrast, presence of soluble LMW-HA did not alter the maximum invasion 
distance compared to non-modified matrices. Furthermore, the increased invasion on covalently 
immobilized LMW-HA is almost complete blocked with an additional presence of soluble LMW-HA 
with only a minor, statistically non-significant increase of maximum invasion distance compared to non-
modified matrices. A similar non-significant increase of maximum invasion distance was observed also 
in the presence of soluble LWM-HA on EDC crosslinked matrices. 
 
Figure 5. Invasion analysis of BRO melanoma cells cultivated on 3D Coll I matrices with and without 
post-modification with EDC crosslinker and HA. Coll I matrices were either crosslinked with EDC (Coll-
EDC) or post-modified with LMW-HA or HMW-HA (cHA: covalently immobilized HA) and optionally 
supplemented with soluble HA (sHA) at concentration of 5 µg/ml. (A) and (B) show the principle of invasion 
analysis for the example of CD44+ BRO melanoma cells in Coll I matrices with immobilized LMW-HA. Cells 
located >20 µm below the Coll I matrix surface were counted as invaded cells. Maximum invasion distance of 
CD44- (C) and CD44+ (D) BRO melanoma cells was defined as the mean invasion distance of 10% of all cells 
with the highest invasion distance. Data are shown as mean. Error bars represent standard deviation of mean. * 
represents statistical significance with p ≤ 0.05.  Experiments were performed at least in 4 independent 
experiments. 
 
These findings suggest that CD44-HA interaction may enhance BRO melanoma cell invasion in 
presence of covalently immobilized LWM-HA. Presence of soluble LMW-HA inhibits this behavior, 
which points to a direct, adhesive interaction of LMW-HA to CD44. In contrast, presence of HMW-HA 
had no specific effect in dependence on presentation form on BRO melanoma cell invasion. In minor, 
non-significant decrease for covalently immobilized HMW-HA compared to Coll I matrices might 
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originate from a non-specific disturbance of the receptor-ligand interaction of other cell surface 
receptors, e.g. integrins, which are important in cell-matrix interaction and cell migration. These results 
are in line with a previous report, which stated immobilized HA, but not soluble, to enhance migration 
of breast tumor cells [66]. 
 
Interaction between CD44 and LMW-HA is stronger than HMW-HA 
To support our hypothesis of a direct adhesive interaction of CD44 with LMW-HA in the discussions 
above, AFM force-distance measurements using the SCP technique was implemented to quantify CD44-
HA interaction on living cells. The schematic methodology of SCP technique was previously published 
[49] and is illustrated in Figure 6A. The SCP technique has the advantage to mimic cell-matrix 
interactions quite closely via the soft hydrogel character of the colloidal probe, the flexible attachment 
of ligands (or receptors) on the well-hydrated probe and the option to form multivalent binding sites due 
to the micrometer sized probe. Furthermore, the low stiffness of the probe in the range of a typical cell 
stiffness (see also Figure S6) allows to directly quantify pull-off forces as a measure of receptor-ligand 
interactions, for details see [49]. As shown in Figure 6B from typical force-distance curves between 
CD44+ and CD44- BRO melanoma cells and LMW-HA modified SCPs at 30s contact time distinct 
difference in cell-SCP interaction can be determined. During retraction the distinct and large pull-off 
force in the presence of CD44 receptor indicates a strong interaction. Importantly, pull-off forces 
between LMW-HA and CD44+ cells were much higher than any other sample, clearly pointing to a 
highly specific and adhesive interaction between LMW-HA and CD44 (e.g. 7.6 ± 2.4 nN at 30 s). LMW-
HA interaction to CD44- cells as well as HMW-HA interaction to CD44+ were much lower (1.5 ± 
1.5 nN, 2.4 ± 0.7 nN at 30 s for LMW-HA/CD44- and HMW/CD44+, respectively). For HWM-HA 
interaction to CD44- cells pull-off forces in the range of non-specific interactions of non-coated SCP 
(0.2 ±  0.1 nN at 30 s, see Figure S7) were observed. 
 
Figure 6. Quantification of CD44-HA interaction using soft colloidal probe technique. (A) Schematic 
illustration of the soft colloidal probe approach as a tool to study HA-CD44 interaction on single living cells. (B) 
Typical force-deformation curves of LMW-HA coated SCPs on CD44+ (blue) and CD44- (black) BRO 
melanoma cells at contact time of 30 s. (C) Measurement of pull-off forces of LMW-HA and HMW-HA on BRO 
melanoma cells with and without CD44 expression at contact times of 0, 1, 3, 10 and 30 s. Data are shown as 
mean from at least 40 cells out of 3 independent experiments. Error bars represents standard deviation of mean. 
 
By investigating various dwell times for CD44-HA interaction between 0 and 30 s, we observed a fast 
onset of CD44-HA engagement during the first 3 s followed by a slower constant increase. The latter 
effect can be attributed to the reorganization of CD44 receptor in the cell membrane and cytoskeletal 
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components in the cell. Especially, the hypothesis of a non-specific intracellular reorganization is 
supported by the similar time dependence for all samples, independent on the specific force magnitude. 
We herein cannot reveal the underlying mechanism between highly adhesive interaction of LMW-HA 
and CD44 and the very weak interaction of HMW-HA. One might speculate on a difference in the 
entropical contribution of the differently sized polymer chains of HA molecules to the physicochemical 
interaction with the CD44 receptor, while other descriptive models on the modulated interaction of 
CD44 with different forms of MW of HA via modulation of CD44 binding stability [67], CD44 
clustering [68] or co-receptors are available as well [26,28]. However, most importantly we can 
quantitatively show that LMW-HA can drive a specific and highly adhesive interaction to CD44 
receptors on living cells, which cannot be observed for HMW-HA or CD44- BRO melanoma cells. 
 
General Discussion 
Our results of proliferative and invasive behavior of BRO melanoma cells in HA-modified Coll 
I matrices led to the conclusion, that CD44 mediated cellular effects are dependent on HA MW and its 
presentation form, being soluble or covalently immobilized. In general, LWM-HA is suggested to 
exhibit a strong direct interaction with CD44, while small effects of HMW-HA are subtler and probably 
indirect. Moreover, in vivo the organization and structural functionalization of HA strains by proteins 
like TSG6, pentraxin 3 and other associated proteoglycans may determine the functionality of HMW-
HA as a part of complex GAG-protein structures in activated tissues like wounds or tumor stroma [69]. 
The HMW-HA confers signals of homeostasis in resting tissue and thus seems to be less stimulating 
than smaller, degraded HA-molecules probably transporting stimulating danger signals. 
Soluble LMW-HA contributed to an enhanced proliferation, which was suggested to result from 
CD44 mediated internalization and downstream signal activation, as immobilized LMW-HA and 
HMW-HA could not act in this manner. Similarly, a strong adhesive interaction of CD44 and LMW-
HA was found in the SCP measurements and only immobilized LMW-HA contributed to an enhanced 
invasion of CD44+ BRO melanoma cells. This interpretation of our results fits to reports arguing direct 
binding of LMW-HA to CD44 activates downstream signaling cascades including the Rho GTPase, the 
Ras-MAPK and the PI3K/AKT pathways [26,70–72]. Cell survival, growth and invasion were therefore 
found to be promoted. Similar effects were obtained by the interaction of CD44 with other cell surface 
receptors, e.g. the oncogenes c-Met and ErbB [26,73]. On the other side, the presence of HMW-HA and 
a high cell density led to the displacement of ERM proteins by hypophosphorylated Merlin and the 
inhibition of the Ras-activated cell growth [74], supporting the more indirect function of HMW-HA. 
Our findings should be also discussed in the context of the multiple functions of CD44 at 
different stages of not only tumor initiation and progression [28]. Although previous studies postulated 
a significant overexpression of activated CD44 of different transcript variants in solid tumors [75,76], 
contrasting effects of CD44 concerning cellular adhesion, proliferation, migration or invasion have been 
reported [23,27]. Our results demonstrate the importance to evaluate MW and binding state of the CD44 
ligand HA in this context to clearly distinguish specific effects. The precise mechanisms of the 
distinction of LMW-HA and HMW-HA (being chemically identical polymers of merely different 
length) by CD44 is an open question. However, the application of defined presentation modes and the 
quantitative adhesion measurements in our study suggest different modes of CD44 dependent HA 
internalization and highly different strength of receptor-ligand interaction as possible reasons for the 
different effects of LMW-HA and HMW-HA as observed in various studies [20,62,63]. 
The importance to distinguish the different effects of immobilized and soluble HA is 
furthermore supported by the fact, that soluble HA can be found in blood and in the lymphatic 
circulation, as well as at degraded tissue and tumor ECM in contrast to its presentation in an immobilized 
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form in the ECM [77,78]. In light of our results on partially antagonistic effects of soluble and covalently 
immobilized LMW-HA on invasion or proliferation for CD44+ BRO melanoma cells multiple cell 
behaviors can be expected for the various physiological and pathological conditions. 
Besides the discussed impact of the different MW of HA and its form of presentation, one has 
to keep in mind, that the interaction between CD44 and HA is cell-type specific, dependent on the CD44 
activation state and determined by cell-specific factors and the present splicing variant of HA receptor 
[68,79]. Moreover, it has been reported that cells differently respond to HA in 2D versus 3D 
microenvironments [80]. 
4. Conclusion 
In this work we use a strategy to present HA of different MW in an immobilized and soluble 
manner within 3D Coll I matrices. The post-modification approach of HA functionalization after Coll I 
fibrillation provided no microstructural changes of Coll I network and stable HA amounts. HA was 
shown to bind in densely packed manner on the Coll I fibrils. These HA-modified Coll I matrices could 
be used to distinguish the interaction of the principal HA receptor CD44 with HA of different MW and 
presentation mode and the CD44 dependent impact on cellular behavior of melanoma cells. LMW-HA, 
but not HMW-HA, was shown to upregulate proliferation by its soluble form and to enhance invasion 
and adhesion by its immobilized form. In sum, our findings strongly support the notion that HA, which 
is found at high concentration in the tumor stroma, can promote tumor growth and invasiveness through 
interaction with its principal surface receptor CD44, and specific MW as well as the presentation form 
of HA regulate this process. 
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